Unlocking Innovation: A Deep Dive into Leading European Biotech Companies in 2025
The European biotech scene has experienced significant changes, from substantial funding increases to more cautious spending.
Despite the shift from the rapid growth of a few years ago, innovation persists, with companies focusing on effective strategies, investors being more selective, and certain regions emerging as key players.
This article examines the current state of leading European biotech companies in 2025, exploring funding trends, scientific advancements, and emerging hotspots.
The European biotech scene has undergone considerable transformation over the past few years, marked by three distinct phases: the pandemic-driven rush, a subsequent market downturn, and the current period of increased selectivity.
It feels like things are getting smarter.
Author's summary: European biotech innovates.